Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Vicarious Surgical ( (RBOT) ).
On March 4, 2026, Vicarious Surgical Inc. amended the executive employment agreements of President Adam Sachs and Chief Technology Officer Sammy Khalifa, with both leaders voluntarily agreeing to reduce their annual base salaries to approximately $270,810 and $318,600, respectively. Despite these salary cuts, the company preserved their pre-amendment base levels for calculating target bonuses and severance, indicating a cost-conscious move that seeks to manage executive compensation while maintaining competitive incentive structures for key management.
The adjustments reflect an effort by Vicarious Surgical to realign cash compensation without undermining long-term incentives that could affect executive retention or performance, a balancing act closely watched by investors and employees. By keeping bonus and severance calculations tied to prior salary levels, the company signals a commitment to financial discipline while attempting to avoid destabilizing leadership incentives during a period that may demand strategic and operational focus.
The most recent analyst rating on (RBOT) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Neutral.
The score is held down primarily by very weak financial performance (no revenue, large ongoing losses, heavy cash burn, and sharply reduced equity). Technicals also remain unfavorable with a clear longer-term downtrend and negative MACD. Offsetting factors include cost-cutting progress and improved cash-burn guidance plus financing actions, but these are not yet enough to outweigh the current funding and execution risk.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical Inc. operates in the medical technology sector, focusing on advanced surgical robotics designed to enhance minimally invasive procedures. The company targets hospitals and surgical centers seeking innovative robotic systems that can improve precision, reduce patient recovery times, and lower overall procedural costs in a competitive medtech landscape.
Average Trading Volume: 124,172
Technical Sentiment Signal: Sell
Current Market Cap: $6.55M
See more data about RBOT stock on TipRanks’ Stock Analysis page.